Send us Fan Mail

For decades, we’ve talked about the digital revolution - but according to Professor Klaus Schwab, we’ve already moved beyond it. We’re now entering what he calls the Intelligent Age - where intelligence itself becomes the most valuable resource on Earth.

Professor Klaus Schwab is Founder of the World Economic Forum and one of the most influential thinkers on how technological and societal systems evolve ( https://schwabacademy.org/klaus-schwab ).

Over more than five decades, Professor Schwab helped shape global conversations around stakeholder capitalism and the Fourth Industrial Revolution - frameworks that examined how digital technologies were transforming economies and institutions.

Now, in a new phase of his work, Professor Schwab has turned his focus to what he calls the “Intelligent Age” - a period defined not just by digital tools, but by the convergence of artificial intelligence, biotechnology, and quantum computing as foundational drivers of society.

Through a series of recent books - including Thriving and Leading in the Intelligent Age, Longevity and Retirement in the Intelligent Age, Restoring Truth and Trust, and Universities in the Intelligent Age - he explores how intelligence itself is becoming the world’s most important resource, and what that means for leadership, education, institutions, and human purpose.

At the core of Professor Schwab's work is a central question:
How do we ensure that as machines become more intelligent, societies become more human?

Important Episode Links -

Schwab Academy - https://schwabacademy.org/

Schwab Foundation for Social Entrepreneurship - https://www.schwabfound.org/home

Global Shapers Community - https://www.globalshapers.org/home

Thriving and Leading in the Intelligent Age: Mastering Change with Purpose - https://www.amazon.com/Thriving-Leading-Intelligent-Age-Mastering/dp/297019547X/ref=tmm_hrd_swatch_0

Longevity and Retirement in the Intelligent Age: Opening New Horizons in Later Life - https://www.amazon.com/Longevity-Retirement-Intelligent-Age-Horizons/dp/2970198800/ref=tmm_pap_swatch_0

Universities, Professors, and Students in the Intelligent Age: A Call for Systems Change - https://www.amazon.com/Universities-Professors-Students-Intelligent-Age/dp/2970198878/ref=tmm_hrd_swatch_0

Restoring Truth and Trust: An Agenda for the Intelligent Age - https://www.amazon.com/Restoring-Truth-Trust-Agenda-Intelligent/dp/2970198835/ref=tmm_pap_swatch_0 

#KlausSchwab #IntelligentAge #ArtificialIntelligence #FutureOfWork #LifelongLearning #FourthIndustrialRevolution #AI #Longevity #FutureOfEducation #DigitalTransformation #HumanCentricAI #Leadership #Innovation #GlobalEconomy #SystemsThinking #FutureOfSociety #EducationReform #AIRevolution #TechnologyTrends #WorkforceTransformation #PurposeDrivenLeadership #Reskilling #Upskilling #FutureTrends #Podcast

Support the show

Send us Fan Mail

What if aging isn’t just biology…but also psychology - and your brain is quietly shaping how fast you age every day?

Dr. Srini Pillay, MD ( https://drsrinipillay.com/ ) is a Harvard-trained psychiatrist, brain researcher, entrepreneur, author, and expert in the science of human potential, resilience, and longevity.

Dr. Pillay previously served as Assistant Professor of Psychiatry at Harvard Medical School and directed both the Outpatient Anxiety Disorders Program and the Panic Disorders Research Program in Brain Imaging at McLean Hospital, one of the world’s leading psychiatric institutions.

Over the course of his career, Dr. Pillay has focused on understanding how the brain shapes performance, creativity, emotional health, leadership, and even biological aging. His work bridges neuroscience, psychiatry, technology, and human behavior - translating cutting-edge brain science into practical tools for individuals, organizations, and healthcare systems.

Dr. Pillay is the co-founder and Chief Medical Officer of Reulay ( https://www.reulay.com/ ), an AI-driven digital therapeutics and mindset technology company focused on healthy longevity, stress reduction, and human performance. He is also founder of the NeuroBusiness Group ( https://nbgcorporate.com/ ), where he works with leaders and organizations around the world on brain-based approaches to innovation, adaptability, resilience, and navigating complexity in the age of AI.

Dr. Pillay is the author of several influential books including Tinker Dabble Doodle Try ( https://www.amazon.com/Tinker-Dabble-Doodle-Try-Unfocused/dp/1101883650 ), which explores the neuroscience of creativity and the untapped power of the brain’s unconscious processing systems.

Today, we’ll explore the fascinating intersection of neuroscience, psychobiology, longevity, mindset, AI-powered therapeutics, creativity, and the future of human performance - and ask how our thoughts, attention, and environments may be shaping our biology far more than we realize.

Important Episode Links - 

Reulay: https://www.reulay.com/mindset?via=dr-srini
Implementing The Science Behind the Law of Attraction: https://loacourse.drsrinipillay.com/special

Dr. Srini Pillay Socials:

IG: https://www.instagram.com/drsrinipillay/
LinkedIn: https://www.linkedin.com/in/drsrinipillay/
Meta: https://www.facebook.com/SriniPillayMD
X: https://x.com/drsrinipillay
TikTOK: https://www.tiktok.com/@dr.srinipillay
Substack: https://drsrinipillay.substack.com/?utm_campaign=profile_chips

Dr. Srini Pillay Free products:

Ideal Self Guide: https://nas.com/drsrini/products/ideal-self-guide
Weekly newsletter on mind-body connection: Sign up here: https://drsrinipillay.com/

Dr. Srini Pillay Paid products:

Book: Tinker Dabble Doodle Try: https://www.amazon.com/Tinker-Dabble-Doodle-Try-Unfocused/dp/1101883650
Book: Life Unlocked: https://www.amazon.com/Life-Unlocked-Revolutionary-Lessons-Overcome/dp/1609611462

#Neuroscience #Longevity #HumanPotential #MindsetMatters #Psychobiology #BrainHealth #AgingScience #Healthspan #MentalHealth #StressManagement #AIHealth #DigitalTherapeutics #Neuroplasticity #FutureOfHealth #HealthTech #WellbeingScience #PerformanceScience #MindBodyConnection #LongevityScience

Support the show

Send us Fan Mail

Dogs can detect explosives, narcotics, missing persons, and even disease. But what if their greatest superpower isn't finding things - it's sensing molecular changes inside the human body long before symptoms appear? Today we're exploring whether the canine nose may hold the key to the next generation of cancer diagnostics.

Itamar Bitan is the Co-Founder of Dognosis  ( https://www.dognosis.tech/ ), a pioneering company working to unlock one of nature's most extraordinary sensing systems - the canine nose - and combine it with cutting-edge brain-computer interfaces and machine learning.

Driven by a passion for both human health and working dogs, Itamar brings together an unusual blend of expertise spanning elite military operations, canine behavior, disease detection, and technology innovation. He spent nearly four years serving in Oketz, the Israeli Defense Forces' elite special operations K9 unit, where he worked as both a combat soldier and commander, developing deep expertise in canine training, scent detection, and high-pressure operational environments.

Following his military service, Itamar became the first employee and Head of Operations at Dog-Prognose, a groundbreaking Israeli startup focused on disease-detection dogs, helping advance the use of canine scent detection for medical applications.

Today, at Dognosis, Itamar and his team are pursuing an ambitious vision: digitizing canine scent perception itself. By combining the remarkable olfactory abilities of trained dogs with brain-computer interfaces, artificial intelligence, and machine learning, Dognosis aims to create a new generation of diagnostic tools capable of detecting diseases - including cancer - earlier, faster, and potentially more accurately than ever before.

Itamar's work raises profound questions about the future of medicine, the untapped biological capabilities of animals, and how technology may help us translate nature's most sophisticated sensing systems into scalable healthcare solutions.

#CancerDetection #ArtificialIntelligence #AI #BrainComputerInterface #BCI #CancerResearch #EarlyDetection #Dogs #MedicalInnovation #Biotechnology #FutureOfMedicine #HealthcareInnovation #MachineLearning #PrecisionMedicine #LiquidBiopsy #CanineDetection #CancerScreening #HealthTech #Diagnostics #SciencePodcast #STEM #Innovation #FutureTech #ProgressPotentialPossibilities

Support the show

Send us Fan Mail

He spent decades interviewing some of the toughest athletes on the planet. Meanwhile, he was quietly battling a condition that at times covered nearly his entire body. Today, for the first time, Paul shares the story behind the story.

Paul is an 11-time Emmy Award-winning sports television producer whose career has taken him behind the scenes of some of the biggest moments in sports and entertainment.

For more than sixteen years, Paul served as a senior producer, helping create acclaimed documentaries, television series, and feature programming seen by millions. Along the way he has interviewed and produced stories featuring some of the most recognizable names in sports and popular culture, including Tom Brady, Peyton Manning, Michael Jordan, Steph Curry, Charles Barkley, Deion Sanders, Eminem, and many others.

Paul has led large-scale productions, won multiple national Emmy Awards, and directed feature-length documentaries, including projects that reached the top of the streaming charts.

But behind that successful career was a challenge most viewers never knew about.

Since childhood, Paul has lived with severe eczema, a chronic inflammatory skin condition that at times affected nearly his entire body. The condition impacted everything from sleep and travel to confidence, comfort, and everyday interactions. For years he largely kept those struggles private while continuing to work in some of the most visible and demanding environments in professional sports media.

Today we'll talk about Paul's remarkable career in sports storytelling, what it was like navigating a visible chronic condition in a culture that often celebrates toughness and silence, and why broader conversations around men's health need to include conditions that affect quality of life, mental well-being, and self-confidence.

Important Episode Links - 

Nemluvio Web Page - https://www.nemluvio.com/

Nemluvio Safety Information - https://www.galderma.com/sites/default/files/2024-12/Nemluvio_Dual%20PI%20for%20website%2013Dec24.pdf

Nemluvio FDA Approval Press - https://www.galderma.com/news/galderma-receives-us-fda-approval-nemluvior-nemolizumab-patients-moderate-severe-atopic

#MensHealth #EczemaAwareness #ChronicIllness #InvisibleIllness #AtopicDermatitis #MentalHealth #HealthAndWellness #SportsMedia #NFLFilms #Resilience #QualityOfLife #HiddenStruggles #Nemluvio #MensHealthMonth #HealthAwareness #PersonalStory #PodcastInterview #ProgressPotentialPossibilities #PPPShow #ChronicDisease #Inspiration

Support the show

Send us Fan Mail

We spend enormous amounts of time trying to extend life - but almost no time learning how to deal with the fact that it ends. And that gap is creating enormous suffering for families.

Dr. Marianne Matzo, Ph.D., FAAN is a nationally recognized gerontologist, hospice nurse, educator, researcher, and advocate whose career has been devoted to one of the most universal - and often avoided - human experiences: dying.

Dr. Matzo is a Fellow of the American Academy of Nursing, one of the profession's highest honors, and served as Professor and the Frances E. and A. Earl Ziegler Chair in Palliative Care Nursing at the University of Oklahoma Health Sciences Center. Over a distinguished academic career, she helped shape the field of palliative care education, co-authoring the first palliative care nursing textbook published in the United States, now in its fifth edition.

Dr. Matzo's research has explored everything from end-of-life communication and assisted dying to sexual health among people living with serious illness, helping to advance both clinical practice and public understanding.

Following her retirement from full-time academia, Dr. Matzo launched the nonprofit organization Everyone Dies ( https://every1dies.org/ ), dedicated to public education about serious illness, dying, death, and bereavement. Through podcasts, educational resources, and children's literature, she is working to transform how Americans think about mortality and helping families navigate some of life's most difficult conversations with greater confidence, compassion, and clarity.

Today we'll explore Dr. Matzo's remarkable career, the evolution of hospice and palliative care, why our culture struggles to discuss death, and what it would mean to build a society that approaches the end of life with wisdom rather than fear.

#DeathEducation #PalliativeCare #HospiceCare #EndOfLifeCare #GriefSupport #Healthcare #MedicalEthics #Aging #Gerontology #AdvanceCarePlanning #HospiceNurse #PublicHealth #Longevity #DeathPositive #SeriousIllness #Caregiving #Wellness #Medicine #Bioethics #EveryoneDies

Support the show

Send us Fan Mail

What if we could recreate the inside of a star - not in theory, but inside a laboratory on Earth using the world’s most powerful lasers?

Dr. Mario Manuel, Ph.D. is a plasma physicist and laser-science researcher at whose work sits at the frontier of fusion energy, laboratory astrophysics, high-energy-density physics, and advanced laser diagnostics. Trained in applied plasma physics and aerospace engineering, Dr. Manuel has spent his career developing new ways to visualize and understand the extreme electromagnetic environments created when ultra-powerful lasers interact with matter.

Dr. Manuel's research has spanned some of the most ambitious scientific efforts underway today - from inertial fusion energy and plasma-instability control to recreating supernova-like shock waves in the laboratory and generating ultra-intense gamma-ray and particle beams using petawatt-class lasers. 

Early in his career, Dr. Manuel helped pioneer advanced proton-radiography techniques capable of imaging invisible electric and magnetic fields inside laser-produced plasmas, work that opened new windows into the turbulent physics that can either enable or destroy fusion reactions.

Today at General Atomics ( https://www.ga.com/ ), Dr. Manuel is involved in next-generation high-repetition-rate laser systems and the GALADRIEL ( https://www.ga.com/galadriel/ ) facility, where researchers are developing the automation, diagnostics, AI-driven optimization, and rapid experimental capabilities that may ultimately make practical laser fusion energy possible. His work also bridges into laboratory astrophysics, where miniature laser-driven plasmas are used to study the same collision-less shocks, turbulence, and magnetic-field generation processes that occur in supernova remnants and other extreme cosmic environments.

With collaborations spanning facilities such as the National Ignition Facility in Livermore, California, and the OMEGA Laser Facility in Rochester, New York, along with partnerships across the fusion-energy and laboratory-astrophysics communities, Dr. Manuel represents a new generation of interdisciplinary scientists using ultra-powerful lasers not only to pursue practical fusion energy, but also to recreate and study some of the most extreme physical processes in the universe. From plasma turbulence and magnetic-field generation to collision-less shocks and high-energy particle acceleration, his work connects the quest for clean energy with the physics of stars, supernovae, and cosmic plasmas.

#fusionenergy #nuclearfusion #nationalignitionfacility #laserscience #plasmaphysics #labastrophysics #supernova #gammaRays #particlephysics #inertialconfinementfusion #cleanenergy #futureofenergy #deeptech #sciencepodcast #generalatomics #livermore #omegaLaser #highenergyphysics #physics #aiinscience #fusionbreakthrough #scienceinterview

Support the show

Send us Fan Mail

What if modern medicine has become incredibly good at saving children’s lives…but society still hasn’t figured out how to help many of those children truly live afterward?

Dr. Nicholas Holekamp, MD is the Chief Health Transformation Officer at Ranken Jordan Pediatric Bridge Hospital in St. Louis ( https://rankenjordan.org/about-us/leadership/nicholas-holekamp-md/ ), one of only a handful of pediatric bridge hospitals in the United States and the only one of its kind in Missouri ( www.RankenJordanFoundation.org ).

For more than two decades, Dr. Holekamp has helped pioneer a radically different approach to caring for children with complex medical conditions through Ranken Jordan’s innovative “Care Beyond the Bedside” model - a philosophy built around a deceptively simple but powerful idea: children heal better when they are active, engaged, social, and out of bed.

Under Dr. Holekamp's leadership, Ranken Jordan evolved from a small 26-bed pediatric nursing facility into a nationally recognized 60-bed specialty hospital focused on helping medically complex children transition safely from intensive hospital care back to home and community life.

A graduate of Dartmouth College and Saint Louis University School of Medicine, Dr. Holekamp completed his pediatric residency at Cardinal Glennon Children’s Medical Center before joining Ranken Jordan in 2000. Along the way, he has become one of the leading voices in pediatric complex care and transitional medicine.

Dr. Holekamp's work has combined clinical care, hospital transformation, and research - including published studies demonstrating how movement, play, environment, and family-centered care can improve outcomes for medically fragile children while potentially reducing healthcare utilization and costs.

Dr. Holekamp has been recognized for both his medical leadership and community impact, including receiving the Missouri Foundation for Health’s Dr. Corinne Walentik Leadership in Health Award and delivering a TEDxStLouis talk on the future of pediatric healing and healthcare transformation.

Today, as Chief Health Transformation Officer, Dr. Holekamp is focused on sharing the lessons of Ranken Jordan with hospitals and healthcare systems across the country - challenging long-held assumptions about what healing environments for children should actually look like.

#Pediatrics #ChildrensHospital #MedicalEthics #HealthcareInnovation #PediatricCare #Neurodevelopment #ChildrenWithMedicalComplexity #HealthcarePodcast #Medicine #PediatricMedicine #HospitalInnovation #CriticalCare #Bioethics #FamilyCenteredCare #HealthcareLeadership #MedicalResearch #VentilatorCare #Rehabilitation #PediatricRehabilitation #FutureOfHealthcare #HealthcareSystems #MedicalTechnology #ProgressPotentialPossibilities #HealthcareTransformation #PediatricICU

Support the show

Send us Fan Mail

Over the last several years, artificial intelligence has transformed from a speculative concept in healthcare into one of the most heavily funded movements in pharmaceutical and biotech history.

But in 2026, the conversation is changing. The question is no longer whether AI can generate molecules, analyze pathology slides, or identify patterns in clinical data. The real question is: which of these technologies can survive the complexity of biology, regulatory scrutiny, clinical validation, and real-world deployment?

Today we’re joined once again by returning guest Bill Taranto, President and Founding Partner of the Merck Global Health Innovation Fund ( https://www.merckghifund.com/ ), alongside Managing Director, Dr. David Rubin, who brings a deep scientific background spanning molecular biology, oncology, precision medicine, and digital health investing.

Together, Bill and David sit at a unique intersection of pharma strategy, venture investing, translational science, and clinical deployment. Through investments across AI-driven drug discovery, precision medicine, diagnostics, and digital health - including early involvement with companies like PathAI - they’ve had a front-row seat to what’s actually working in AI-enabled healthcare…and what still breaks down when these systems encounter real-world medicine.

Today we’ll explore where AI is genuinely creating value across the pharmaceutical stack, why some approaches are beginning to achieve meaningful validation, what investors and pharma companies are now demanding beyond hype, and how entirely new experimental models - from organoids to AI-native biology platforms - may reshape the future of drug development.

#AI #ArtificialIntelligence #DrugDiscovery #Biotech #Pharma #HealthcareAI #PrecisionMedicine #DigitalHealth #Oncology #PathAI #Roche #Biology #MachineLearning #BiotechInvesting #VentureCapital #Merck #DigitalPathology #ClinicalTrials #FutureOfMedicine #LifeSciences #AIHealthcare #MedicalInnovation #Biotechnology #CancerResearch #PrecisionOncology #Bioinformatics #HealthcareInnovation #Pharmaceuticals #MedTech #ProgressPotentialPossibilities

Support the show

Send us Fan Mail

For decades, agriculture and energy were treated as separate worlds. But what happens when farms become part of the global energy infrastructure? Ofer Haviv joins us to discuss the rise of castor as a next-generation industrial crop, the future of sustainable aviation fuel, and how AI-driven biology is transforming agriculture itself.

Ofer Haviv is CEO of Casterra ( https://casterra.co/ ) and longtime President and CEO of Evogene ( https://evogene.com/ ), one of the pioneers in computational biology and AI-driven agricultural innovation.

For more than two decades, Ofer has helped lead the transformation of crop science from traditional breeding into a data-driven discipline powered by predictive biology, artificial intelligence, and advanced genomics. He played a key role in Evogene’s spin-off from Compugen in 2002 and has guided the company through its evolution into a global computational biology platform with applications spanning agriculture, human health, industrial biotechnology, and sustainable materials.

Today, Ofer also serves as CEO of Casterra, an Evogene subsidiary focused on transforming castor farming into a scalable industrial platform for the future bioeconomy. Through elite castor seed varieties and integrated farming solutions, Casterra is helping address growing global demand for sustainable feedstocks used in biofuels, aviation fuel, lubricants, polymers, cosmetics, and other bio-based industries.

With increasing pressure on the world to decarbonize transportation, strengthen energy security, and develop more sustainable industrial supply chains, Casterra’s work sits at the convergence of agriculture, climate technology, and renewable energy innovation.

Ofer holds a degree in Economics and Accounting from Tel Aviv University and is a Certified Public Accountant in Israel.

#OferHaviv #Casterra #Evogene #Biofuels #SustainableAviationFuel #SAF #ClimateTech #Agriculture #AgTech #Biotech #AI #ArtificialIntelligence #ComputationalBiology #RenewableEnergy #GreenEnergy #FutureOfEnergy #IndustrialBiotech #Castor #SustainableFarming #EnergyTransition #Bioeconomy #CarbonNeutral #FutureTech #ClimateInnovation #CleanTech #Aviation #JetFuel #SustainableTechnology #FoodTech #PrecisionAgriculture

Support the show

Send us Fan Mail

Every once in a while, a simple question changes medicine forever.

For decades, chronic and traumatic wounds were among the most frustrating problems in healthcare. Doctors could clean wounds, dress wounds, and hope for healing - but many patients remained trapped in cycles of infection, inflammation, and failed recovery.

Then came one deceptively simple idea:  What happens if you apply vacuum?

That question led to the creation of Vacuum Assisted Closure - better known worldwide as V.A.C.® Therapy ( https://www.solventum.com/en-us/home/medical/advanced-wound-care/negative-pressure-wound-therapy/vac-therapy/ ) - developed by plastic surgeon Dr. Louis Argenta and biomedical engineer Dr. Michael Morykwas ( https://www.renovoconcepts.com/michaelmorykwasbio ).

The technology transformed wound care by using controlled negative pressure to remove fluid, stimulate blood flow, encourage tissue growth, and accelerate healing. What began as a bold experiment evolved into one of the most important advances in modern medicine, helping more than 20 million patients worldwide - from burn victims and diabetic patients to wounded soldiers returning from Iraq and Afghanistan.

For this groundbreaking work, Drs. Argenta and Morykwas were inducted into the National Inventors Hall of Fame ( https://www.invent.org/inductees/michael-morykwas ).

Today, we’re joined by Dr. Michael Morykwas - bioengineer, inventor, scientist, and lifelong tinkerer - to explore the origins of this revolutionary technology, the science behind mechanobiology and wound healing, the long road from prototype to global adoption, and what the future of regenerative medicine may look like next.

Photo Credit - National Inventors Hall of Fame 

#MichaelMorykwas #VACtherapy #WoundHealing #RegenerativeMedicine #Mechanobiology #BiomedicalEngineering #MedicalInnovation #NegativePressureWoundTherapy #TissueEngineering #HealthcareInnovation #PlasticSurgery #Bioengineering #MedicalBreakthrough #Inventor #NationalInventorsHallOfFame #RegenerativeScience #MilitaryMedicine #FutureOfMedicine #MedTech #SciencePodcast #InnovationPodcast #HealthcareTechnology #StemCells #WoundCare #MedicalScience

Support the show